Comparing Behavioral Assessments Using Telehealth for Children With Autism
Launched by MATTHEW J O'BRIEN, PHD, BCBA-D · May 27, 2015
Trial Information
Current as of June 21, 2025
Completed
Keywords
ClinConnect Summary
Managing challenging behavior in autism spectrum disorders (ASD) can profoundly improve quality of life for children and families. However, many families lack access to research-based treatment, such as applied behavior analysis (ABA). This study is a randomized trial comparing outcomes of treatment for ASD using either a standard Functional Analysis Plus Functional Communication Training (FA+FCT) package or a pragmatic version that offers a briefer, less time-intensive model of FA+FCT. Both types of FA+FCT are provided via telehealth in family homes to maximize generalizability to real-lif...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Confirmed diagnosis of autism spectrum disorder
- • Significant behavior problems requiring treatment
- • At least one parent willing to be trained in behavior analysis via telehealth
- Exclusion Criteria:
- • Unstable or degenerative neurological disorder
About Matthew J O'brien, Phd, Bcba D
Dr. Matthew J. O'Brien, PhD, BCBA-D, is a distinguished clinical trial sponsor with extensive expertise in behavioral analysis and research methodologies. As a Board Certified Behavior Analyst-Doctoral (BCBA-D), Dr. O'Brien combines his deep understanding of behavioral science with a commitment to advancing evidence-based practices in clinical settings. His leadership in clinical trials focuses on innovative interventions and therapeutic strategies aimed at improving outcomes for individuals with developmental and behavioral challenges. With a strong emphasis on rigorous scientific protocols and ethical considerations, Dr. O'Brien is dedicated to contributing to the advancement of knowledge and best practices in the field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Iowa City, Iowa, United States
Patients applied
Trial Officials
Matthew J O'Brien, PhD
Principal Investigator
University of Iowa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials